Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Journal of Medicinal Chemistry|October 5, 2020
Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitorsNilanjan Adhikari, Sandip Kumar Baidya, Tarun Jha
European Journal of Medicinal Chemistry|December 6, 2020
Outline of gelatinase inhibitors as anti-cancer agents: A patent mini-review for 2010-presentSandip Kumar Baidya, Sk Abdul Amin, Tarun Jha
Journal of Medicinal Chemistry|August 15, 2022
Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug DiscoverySandip Kumar Baidya, Suvankar Banerjee, Nilanjan Adhikari, et al.
Expert Opinion on Therapeutic Patents|November 20, 2023
An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Journal of Molecular Structure|December 6, 2021
Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidencesNilanjan Adhikari, Suvankar Banerjee, Sandip Kumar Baidya, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 26, 2025
Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction AnalysisSuvankar Banerjee, Sandip Kumar Baidya, Tarun Jha, et al.
Journal of Molecular Graphics & Modelling|November 17, 2023
A fragment-based exploration of diverse MMP-9 inhibitors through classification-dependent structural assessmentSandip Kumar Baidya, Suvankar Banerjee, Balaram Ghosh, et al.
Journal of Molecular Structure|December 5, 2022
Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidencesSuvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Heliyon|December 10, 2024
Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategiesSuvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh, et al.
Current Topics in Medicinal Chemistry|April 11, 2023
Hydrazides as Potential HDAC Inhibitors: Structure-activity Relationships and Biological ImplicationsSuvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Pageof 2